malcolm wrote: ↑Wed Mar 15, 2023 4:21 pm
but it's funny how all viruses mutate overtime so they don't kill the hosts.
That's exactly what coronaviruses do.
If you consider the best way for a virus to continue to survive, it needs to be able to spread itself effectively throughout a host population, and maintain that over time.
The best scenario is a virus that is very infectious (high R number) and easily passed on to another host.
But if you kill your host (eg Ebola with 50 to 70% mortality) the infection quickly burns out. Not good for the virus long term.
Similarly you want your host to be able interact with as many other potential hosts as possible. So a relatively mild disease with, ideally, a lot of shedding of virus over the longest period possible. You're a bit sick, with a runny nose and a cough but you still go to work and soldier your way around Sainsbury's.
The final thing the virus wants is to be able to reinfect the same host again later. So it needs to change its immune signature enough that the host still catches the disease next time. Coronaviruses' strategy is constant mutation.
The problem with mutation is that while it has many benefits it also has a downside, which is alterations in the pathogenicity, infectiveness or other effects on the host. So every now and then there's a mutation that produces unexpected effects in infected hosts.
The initial strains of Covid in 2019 had mutated in a way that made them much more pathogenic than the usual coronavirus, resulting in a 1% death rate.
The whole pandemic thing is quite interesting.
Coronaviruses (aka the common cold) are endemic in our population and always have been. Everyone gets a cold every now and then. And we keep getting them because it mutates. Prior to Covid, despite a fair bit of effort, no one successfully produced a vaccination against the common cold, as much as anything because of the coronaviruses' immune mutagenicity.
So logically, all of this has happened before, from time to time. Every (decades/century?) a coronavirus emerges with a bad mutation that kills lots of people.
So what was different in 2019? One major thing. PCR.
In 1995 I did a stint of my anaesthetic training in ICU. This is a requirement. That winter we had an unusually high number of ICU admissions and deaths due to what we called "atypical pneumonia". We assumed it was viral, antibiotics made no difference, we had no effective antivirals at all and we never worked out what the causative virus was.
Back then the only way to ID the pathogen was to measure patient antibody titres. These take days or weeks to rise after infection and if the patient dies within 48 hours you can't ever measure them.
And I only saw the patients who were presented for ICU admission. The frail elderly in nursing homes mostly never even made it to hospital, never mind being considered as ICU candidates.
But roll on to 2019 and suddenly you had PCR and this was an absolute game changer. You could know what the infectious agent was within 24 hours.
The ability to identify Covid infection enabled public health strategies to minimise the spread of the virus (lockdown and isolation), development of effective antiviral medication (previously undreamed of) and to produce an effective vaccine.
So in 1995 we looked back after winter a bit nonplussed and felt that it had been an unusually bad time, but had absolutely no idea what had caused it and didn't even know how many people had died.
Roll on to now, and with PCR the causative agent is right there in the spotlight.